Almotriptan Malate Patent Expiration
Almotriptan Malate is Used for relieving symptoms of migraines. It was first introduced by Janssen Pharmaceuticals Inc
Almotriptan Malate Patents
Given below is the list of patents protecting Almotriptan Malate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Axert |
US5565447 (Pediatric) | Indole derivatives |
Nov 07, 2015
(Expired) | Janssen Pharms |
| Axert | US5565447 | Indole derivatives |
May 07, 2015
(Expired) | Janssen Pharms |
Almotriptan Malate's Family Patents
Explore Our Curated Drug Screens
Almotriptan Malate Generic API Manufacturers
Several generic applications have been filed for Almotriptan Malate. The first generic version for Almotriptan Malate was by Teva Pharmaceuticals Usa and was approved on Jul 7, 2015. And the latest generic version is by Ajanta Pharma Ltd and was approved on Mar 3, 2016.
Given below is the list of companies who have filed for Almotriptan Malate generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Almotriptan Malate. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6.25MG BASE | tablet | Prescription | ORAL | AB | Mar 3, 2016 |
| EQ 12.5MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Mar 3, 2016 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Almotriptan Malate. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6.25MG BASE | tablet | Prescription | ORAL | AB | Nov 9, 2015 |
| EQ 12.5MG BASE | tablet | Prescription | ORAL | AB | Nov 9, 2015 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
3. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Almotriptan Malate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6.25MG BASE | tablet | Prescription | ORAL | AB | Jul 7, 2015 |
| EQ 12.5MG BASE | tablet | Prescription | ORAL | AB | Jul 7, 2015 |